Researchers find key genetic trigger of depression

October 17, 2010

(PhysOrg.com) -- Yale University researchers have found a gene that seems to be a key contributor to the onset of depression and is a promising target for a new class of antidepressants, they report Oct. 17 in the journal Nature Medicine.

"This could be a primary cause, or at least a major contributing factor, to the signaling abnormalities that lead to depression," said Ronald S. Duman, professor of psychiatry and pharmacology at Yale and senior author of the study.

Scientists have had a difficult time pinning down the cause of depression, which afflicts almost 16 percent of Americans in any given year and carries an annual economic burden of $100 billion.

Symptoms of depression vary widely among individuals. Most now believe that multiple physiological processes are involved in . That explains why people respond differently to most commonly prescribed antidepressants, which work by manipulating the uptake of the neurotransmitter serotonin. However, as many as 40 percent of depressed patients do not respond to currently available medications, which take weeks to months to produce a therapeutic response.

Duman's team did whole genome scans on tissue samples from 21 deceased individuals who had been diagnosed with depression and compared gene expression levels to those of 18 individuals who had not been diagnosed with depression. They found that one gene called MKP-1 was increased more than two-fold in the brain tissues of depressed individuals.

This was particularly exciting, say the researchers, because the gene inactivates a molecular pathway crucial to the survival and function of neurons and its impairment has been implicated in depression as well as other disorders. Duman's team also found that when the MKP-1 gene is knocked out in mice, the mice become resilient to stress. When the gene is activated, mice exhibit symptoms that mimic depression.

The finding that a negative regulator of a key neuronal signaling pathway is increased in depression also identifies MKP-1 as a potential target for a novel class of therapeutic agents, particularly for treatment resistant .

Related Stories

Recommended for you

Suicidal thoughts rapidly reduced with ketamine, finds study

December 14, 2017
Ketamine was significantly more effective than a commonly used sedative in reducing suicidal thoughts in depressed patients, according to researchers at Columbia University Medical Center (CUMC). They also found that ketamine's ...

Do bullies have more sex?

December 14, 2017
Adolescents who are willing to exploit others for personal gain are more likely to bully and have sex than those who score higher on a measure of honesty and humility. This is according to a study in Springer's journal Evolutionary ...

Children's screen-time guidelines too restrictive, according to new research

December 14, 2017
Digital screen use is a staple of contemporary life for adults and children, whether they are browsing on laptops and smartphones, or watching TV. Paediatricians and scientists have long expressed concerns about the impact ...

The iceberg model of self-harm

December 14, 2017
Researchers have created a model of self-harm that shows high levels of the problem in the community, especially in young girls, and the need for school-based prevention measures.

Eating together as a family helps children feel better, physically and mentally

December 14, 2017
Children who routinely eat their meals together with their family are more likely to experience long-term physical and mental health benefits, a new Canadian study shows.

Anti-stress compound reduces obesity and diabetes

December 13, 2017
For the first time, scientists from the Max Planck Institute of Psychiatry in Munich could prove that a stress protein found in muscle has a diabetes promoting effect. This finding could pave the way to a completely new treatment ...

4 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

otto1932
1.3 / 5 (15) Oct 17, 2010
Hopefully the researchers factored the possibility of prenatal brain and neurological damage from alcohol, tobacco, and such. These things are definitely known to result in depression:

"Mental health problems - Diagnosed with ADHD, Clinical Depression, or other mental illness, experienced by over 90% of the subjects"

-In FAS cases alone:
http://en.wikiped...syndrome
Zeke65
2.3 / 5 (3) Oct 18, 2010
Sounds like hopeful shilling for an industry that is wholly dependent on government protection or support to continue to exist. They did not find anything;

"Yale University researchers have found a gene that SEEMS to be a key contributor to the onset of depression and is a promising target for a new class of antidepressants"

And,

"This COULD be a primary cause, or at least a major CONTRIBUTING FACTOR, to the signaling abnormalities that lead to depression," said Ronald S. Duman,"

And,

"The finding that a negative regulator of a key neuronal signaling pathway is increased in depression also identifies MKP-1 as a POTENTIAL TARGET for a novel class of therapeutic agents, particularly for treatment resistant depression." - (Emphasis added.)

All that was done by the drugging-knifing-electroshocking quacks was to justify human experimentation with new,expensive and likely damaging drugs. Is it not a forgone conclusion that they will be found to be effective?
Berry
5 / 5 (1) Oct 19, 2010
Good science is always couched in cautious language. It is psuedo-science that is 100 percent certain of everything, even if they are wrong (which is often).
junkd
not rated yet Nov 28, 2010
Reliable supplier, rapid delivery, guarantee!
http://star-of-he..._id=5831

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.